KLRK1 and breast cancer: As SeNPs upregulate the receptor NKG2D and its ligands expression and activation in CIK, they can be combined with CIK cells to both prolong the in vivo persistence of these cells in peripheral blood and enhance the cytotoxicity of CIK cells from breast cancer patients to tumor cells.